A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin.

Autor: Gordon, F. H.¹ (AUTHOR), Hamilton, M. I.¹ (AUTHOR), Donoghue, S.² (AUTHOR), Greenlees, C.² (AUTHOR), Palmer, T.² (AUTHOR), Rowley‐Jones, D.² (AUTHOR), Dhillon, A. P.³ (AUTHOR), Amlot, P. L.⁴ (AUTHOR), Pounder, R. E.¹ (AUTHOR)

Publikováno v: Alimentary Pharmacology & Therapeutics. Apr2002, Vol. 16 Issue 4, p699-705. 7p.

Autoimmunity in ulcerative colitis: tropomyosin is not the major antigenic determinant of the Das monoclonal antibody, 7E12H12.

Autor: Hamilton, M. I.¹, Bradley, N. J.², Srai, S. K. S.³, Thrasivoulou, C.⁴, Pounder, R. E.¹, Wakefield, A. J.¹

Publikováno v: Clinical & Experimental Immunology. Mar1995, Vol. 99 Issue 3, p404-411. 8p.

Review article: infective complications of therapeutic gastric acid inhibition.

Autor: LARNER, J., HAMILTON, M. I. R.

Publikováno v: Alimentary Pharmacology & Therapeutics; Dec1994, Vol. 8 Issue 6, p579-584, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.

Autor: Gordon FH; Centre for Gastroenterology, Department of Medicine, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, England. fionagordon@ownhomeline.freeserve.co.uk, Lai CW, Hamilton MI, Allison MC, Srivastava ED, Fouweather MG, Donoghue S, Greenlees C, Subhani J, Amlot PL, Pounder RE

Publikováno v: Gastroenterology [Gastroenterology] 2001 Aug; Vol. 121 (2), pp. 268-74.